Dermavant Sciences Ltd Purchase Agreements
3 Contracts & Agreements
- Asset Purchase Agreement, dated May 29, 2012, by and between Glaxo Group Limited and Welichem Biotech Inc., as amended (Filed With SEC on May 24, 2019)
- China and South Korea IP Purchase Agreement, effective as of June 12, 2017, by and between Dermavant Sciences GmbH and Roivant Sciences GmbH (Filed With SEC on May 24, 2019)
- Asset Purchase Agreement, dated as of July 10, 2018, by and among Dermavant Sciences GmbH, GlaxoSmithKline Intellectual Property Development Ltd. and Glaxo Group Limited (Filed With SEC on May 24, 2019)
